Denver, Colorado
Mydecine Innovations Group
Founded:
2020
Co-founder and CEO Josh Bartch sees a big future for psilocybin and other mushroom-derived compounds in both pharmaceuticals and consumer packaged goods.
Gallery
Featured on CompanyWeek:
Mydecine Innovations Group
Co-founder and CEO Josh Bartch sees a big future for psilocybin and other mushroom-based compounds in both pharmaceuticals and consumer packaged goods.
